VTR
54
2
APD
37
-3
PYPL
24
2
ADM
28
-3
TSCO
46
-3
INTC
29
6
D
38
-3
XOM
56
2
NFLX
62
4
CFG
40
10
PLD
41
4
PSX
42
17
SHW
50
-3
DD
34
-2
CNX
46
-2
HP
32
2
KHC
38
-2
BBY
34
-7
CHRW
50
-3
NTAP
37
2
VTR
54
2
APD
37
-3
PYPL
24
2
ADM
28
-3
TSCO
46
-3
INTC
29
6
D
38
-3
XOM
56
2
NFLX
62
4
CFG
40
10
PLD
41
4
PSX
42
17
SHW
50
-3
DD
34
-2
CNX
46
-2
HP
32
2
KHC
38
-2
BBY
34
-7
CHRW
50
-3
NTAP
37
2
Financhill
Back

First Business Financial Services Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
59

FBIZ
First Business Financial Services

Last Price:
$46.96
Seasonality Move:
1.46%
Buy
54

DRUG
Bright Minds Biosciences

Last Price:
$35.94
Seasonality Move:
-28.52%
Buy
59
First Business Financial Services (FBIZ) is a Buy

Is First Business Financial Services a Buy, Sell or Hold?

  • The current First Business Financial Services [FBIZ] share price is $47.12. The Score for FBIZ is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • FBIZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FBIZ Stock Price Chart

What is First Business Financial Services's stock price today?

  • The First Business Financial Services share price today is $47.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIZ is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $36.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

FBIZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 33.76 Sell
Chaikin Money Flow: 4048 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.02 - 54.9) Sell
Bollinger Bands (100): (45.04 - 51.96) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 50.3 Buy
Chaikin Money Flow: 47724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.85 - 42.25) Sell
Bollinger Bands (100): (33.67 - 45.15) Sell

FBIZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.71 Sell
20-day SMA: 51.93 Sell
50-day SMA: 49.42 Sell
200-day SMA: 44.27 Buy
8-day EMA: 49.2 Sell
20-day EMA: 50.61 Sell
50-day EMA: 50.07 Sell
200-day EMA: 45.16 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.16 Buy
20-day SMA: 37.2 Sell
50-day SMA: 37.07 Sell
200-day SMA: 20.27 Buy
8-day EMA: 35.28 Buy
20-day EMA: 36.12 Buy
50-day EMA: 36.52 Sell
200-day EMA: 24.96 Buy

First Business Financial Services Earnings Growth & FBIZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.65 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.

First Business Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):